|
|
Volumn 17, Issue 6, 2011, Pages 1443-1444
|
|
Mycobacterium marinum infection in the setting of antitumor necrosis factor alpha therapy for Crohn's disease
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ABATACEPT;
ADALIMUMAB;
AMOXICILLIN;
AZATHIOPRINE;
BRIAKINUMAB;
CEFALEXIN;
DOXYCYCLINE;
INFLIXIMAB;
MERCAPTOPURINE;
MINOCYCLINE;
RIFAMPICIN;
TUMOR NECROSIS FACTOR ALPHA ANTIBODY;
ABDOMINAL PAIN;
BACTERIUM CULTURE;
COLON CROHN DISEASE;
COLON RESECTION;
COLONOSCOPY;
COLOSTOMY;
CONTRAST ENHANCEMENT;
CROHN DISEASE;
DEBRIDEMENT;
DISEASE DURATION;
DRUG WITHDRAWAL;
HAND INJURY;
HUMAN;
ILEOCECAL VALVE;
ILEUM;
LETTER;
MEDICAL RECORD REVIEW;
MONOTHERAPY;
MYCOBACTERIOSIS;
MYCOBACTERIUM MARINUM;
MYCOBACTERIUM MARINUM INFECTION;
NAUSEA AND VOMITING;
NUCLEAR MAGNETIC RESONANCE IMAGING;
PAPULE;
POSTOPERATIVE CARE;
PRIORITY JOURNAL;
SKIN DEFECT;
SUBCUTANEOUS NODULE;
TREATMENT DURATION;
ADULT;
ANTIBODIES, MONOCLONAL;
CROHN DISEASE;
FEMALE;
HUMANS;
IMMUNOSUPPRESSIVE AGENTS;
MALE;
MIDDLE AGED;
MYCOBACTERIUM INFECTIONS, ATYPICAL;
MYCOBACTERIUM MARINUM;
TUMOR NECROSIS FACTOR-ALPHA;
|
|
EID: 79955822890
PISSN: 10780998
EISSN: 15364844
Source Type: Journal
DOI: 10.1002/ibd.21512 Document Type: Letter |
|
Times cited : (8)
|
|
References (7)
|
